← All trials
NCT00121823
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2004
- Primary completion
- —
- Completion date
- Dec 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- University of OxfordCollaborator
- Bill and Melinda Gates FoundationStudy director
- Medical Research Council, The GambiaCollaborator
- Wellcome TrustCollaborator
- University of LondonReponsible party - principal investigator
- University of OxfordStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.